🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.88
-0.07 (-0.70%)
Nov 20, 2026, 4:00 PM EST - Market closed

Bioventus Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
585.64568.09573.28512.35512.12430.9
Revenue Growth
3.87%-0.91%11.89%0.04%18.85%34.17%
Cost of Revenue
183.29179.93185.05184.15181.04128.19
Gross Profit
402.35388.16388.23328.19331.08302.71
Selling, General & Admin
326.72313.98330303.88332.13254.25
Research & Development
12.0812.1113.9513.4523.8519.04
Operating Expenses
343.3331.82351.6326.17365.74281.66
Operating Income
59.0556.3436.632.03-34.6621.05
Interest Expense
-17.46-26.49-38.79-40.68-18.42-3.84
Interest & Investment Income
----6.42.73
Earnings From Equity Investments
------1.87
Currency Exchange Gain (Loss)
4.291.981.310.35-0.25-0.13
Other Non Operating Income (Expenses)
-3.43-3.430.340.940.771.91
EBT Excluding Unusual Items
42.4428.4-0.52-37.36-46.1619.85
Merger & Restructuring Charges
-2.27-2.240.05-0.84-6.78-2.49
Impairment of Goodwill
-----124.7-
Gain (Loss) on Sale of Investments
-----10.29-7.04
Gain (Loss) on Sale of Assets
--0.08-0.29-3.58--
Asset Writedown
---36.36-78.62--
Legal Settlements
-0.04-0.05-13.8---
Other Unusual Items
--0.33-1.42-0.72-1.1-0.83
Pretax Income
40.1325.71-52.34-121.11-189.039.49
Income Tax Expense
-24.2-1.57-5.290.09-44.37-1.97
Earnings From Continuing Operations
64.3327.27-47.05-121.2-144.6511.45
Earnings From Discontinued Operations
----59.49-54.79-1.87
Net Income to Company
64.3327.27-47.05-180.69-199.449.59
Minority Interest in Earnings
-7.03-4.5410.9224.4640.739.79
Net Income
57.322.73-36.13-156.23-158.719.38
Preferred Dividends & Other Adjustments
-----25.98
Net Income to Common
57.322.73-36.13-156.23-158.7-6.6
Net Income Growth
654.99%-----
Shares Outstanding (Basic)
686765636145
Shares Outstanding (Diluted)
716965636145
Shares Change
3.97%6.77%3.03%2.05%35.00%828.01%
EPS (Basic)
0.850.34-0.56-2.49-2.59-0.15
EPS (Diluted)
0.810.33-0.56-2.49-2.59-0.15
EPS Growth
605.99%-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
84.9972.1137.797.98-25.069.47
Free Cash Flow Per Share
1.201.050.580.13-0.410.21
Gross Margin
68.70%68.33%67.72%64.06%64.65%70.25%
Operating Margin
10.08%9.92%6.39%0.40%-6.77%4.88%
Profit Margin
9.78%4.00%-6.30%-30.49%-30.99%-1.53%
Free Cash Flow Margin
14.51%12.69%6.59%1.56%-4.89%2.20%
EBITDA
77.4977.6455.7628.85-4.6841.52
EBITDA Margin
13.23%13.67%9.73%5.63%-0.91%9.64%
D&A For EBITDA
18.4521.319.1426.8229.9720.47
EBIT
59.0556.3436.632.03-34.6621.05
EBIT Margin
10.08%9.92%6.39%0.40%-6.77%4.88%
Advertising Expenses
-4.144.423.855.23.87
SEC Filings: 10-K · 10-Q